Rather visceral fat, which is found in and around abdominal organs including the stomach, liver and intestines, is the driver of metabolic disease, says Kessler
GLP-1RAs, including exenatide, albiglutide, dulaglutide, and lixisenatide, demonstrated remarkable efficacy in improving glycemic control by lowering postprandial glucose levels and HbA1c
Furthermore, Zepbound is being studied for sleep apnea and, with FDA Fast Track designation, results are expected to be submitted to the FDA midyear 2024
How does the article's incidence table compare against placebo
Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, et al
A single 30mg vial at 12mg weekly lasts longer than a 20mg vial, reducing your reconstitution frequency and keeping your protocol cleaner